All data are based on the daily closing price as of December 24, 2024
b

BioNote

377740.KO
3.32 USD
-0.03
-0.90%

Overview

Last close
3.32 usd
Market cap
338.04M usd
52 week high
4.55 usd
52 week low
2.69 usd
Target price
3.91 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
5.2354
Price/Book Value
0.311
Enterprise Value
66.50M usd
EV/Revenue
0.9722
EV/EBITDA
1.5814

Key financials

Revenue TTM
64.57M usd
Gross Profit TTM
351.80M usd
EBITDA TTM
-23.79M usd
Earnings per Share
N/A usd
Dividend
0.14 usd
Total assets
1.33B usd
Net debt
N/A usd

About

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
  • Symbol
    377740.KO
  • Exchange
    KO
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
  • Headquarter
    Hwaseong-si
  • Web site
    https://www.bionote.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top